These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26614964)

  • 1. Should HIV testing week be blood-borne-virus testing week?
    Orkin C; Wallis E
    Lancet HIV; 2015 Dec; 2(12):e510-1. PubMed ID: 26614964
    [No Abstract]   [Full Text] [Related]  

  • 2. Testing times.
    Lancet HIV
    Lancet HIV; 2015 Nov; 2(11):e451. PubMed ID: 26520919
    [No Abstract]   [Full Text] [Related]  

  • 3. Expanded blood borne virus testing in a tuberculosis clinic. A cost and yield analysis.
    Sewell J; Capocci S; Johnson J; Solamalai A; Hopkins S; Cropley I; Webster DP; Lipman M
    J Infect; 2015 Apr; 70(4):317-23. PubMed ID: 25452045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance.
    Uuskula A; Heimer R; Dehovitz J; Fischer K; McNutt LA
    J Infect Dis; 2006 Feb; 193(3):455-7. PubMed ID: 16388495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The assessment of economic loss during detection and examination of hemocontact virus hepatitis and HIV].
    Mar'in GG; Mel'nichenko PI; Novikov VA
    Voen Med Zh; 2007 Feb; 328(2):46-8. PubMed ID: 17508612
    [No Abstract]   [Full Text] [Related]  

  • 6. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
    Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
    Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low prevalence of transfusion-transmissible infections among voluntary blood donors in South India.
    Mythreyee M; Jayachandran C; Amudhan M; Sivashankar M; Mythily N; Sekar R
    J Infect Dev Ctries; 2011 May; 5(5):410-2. PubMed ID: 21628822
    [No Abstract]   [Full Text] [Related]  

  • 8. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania.
    Matee MI; Magesa PM; Lyamuya EF
    BMC Public Health; 2006 Jan; 6():21. PubMed ID: 16445860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis C virus: first pathogen found in blood donors in Burundi].
    Ndihokubwayo JB; Ntirandekura D; Nzotungwanayo I; De Lamballerie X
    Med Trop (Mars); 1999; 59(3):307. PubMed ID: 10701213
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan.
    Achakzai M; Kassi M; Kasi PM
    Trop Doct; 2007 Jan; 37(1):43-5. PubMed ID: 17326891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests].
    Sabbatani S; Giuliani R; Fulgaro C; Paolillo P; Baldi E; Chiodo F
    Epidemiol Prev; 2004; 28(3):163-8. PubMed ID: 15532873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service.
    Craine N; Parry J; O'Toole J; D'Arcy S; Lyons M
    J Viral Hepat; 2009 Mar; 16(3):219-22. PubMed ID: 19175879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-HB-core antibodies as a surrogate marker in blood donors].
    Blejer JL; Saguier MC; Salamone HJ
    Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590
    [No Abstract]   [Full Text] [Related]  

  • 16. Nosocomial outbreak of multiple bloodborne viral infections.
    Yerly S; Quadri R; Negro F; Barbe KP; Cheseaux JJ; Burgisser P; Siegrist CA; Perrin L
    J Infect Dis; 2001 Aug; 184(3):369-72. PubMed ID: 11443566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of triplex nucleic acid test assays in United States blood donors.
    Stramer SL; Krysztof DE; Brodsky JP; Fickett TA; Reynolds B; Dodd RY; Kleinman SH
    Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus.
    Pontali E; Ferrari F
    Int J Prison Health; 2008; 4(2):77-82. PubMed ID: 18464061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
    Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood screening--the next generation in testing.
    Chappel RJ; Dax EM
    Aust N Z J Med; 1999 Dec; 29(6):763-4. PubMed ID: 10677118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.